We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector.

Auguston kicked off an animated session titled “The People Factor” by outlining all the ways in which the CEO role in ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Artificial intelligence (AI) and the Internet of Things (IoT) are about to revolutionize the biopharmaceutical industry.

European equities traded in the US as American depositary receipts were lower late Wednesday morning, declining 0.21% to 1,391.26 on the S&P Europe Select ADR Index. From continental Europe, the ...

PharmaCord is a Jeffersonville, Indiana-based provider of patient services for the biopharmaceutical industry, and Mercalis, a Morrisville, North Carolina-based provider of life sciences and ...

As the U.S. stock market faces a sell-off driven by concerns over tariffs and economic uncertainty, investors are increasingly looking for opportunities that can offer resilience and potential growth.

Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...

Rhumbline Advisers increased its position in Can-Fite BioPharma Ltd. (NYSE:CANF – Free Report) by 58.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...

ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) is one of 1,068 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We ...

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...